BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for Feb. 24, 2026

Feb. 24, 2026
Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: Alkem, Aska, Axsome, Bostongene, Celltrion, Centessa, Cumulus Neuroscience, CSL, Daiichi Sankyo Formycon, HCW Biologics, I-sens, Lifescan, Lotus, Memo, Nxera, Shionogi, Teijin, WY.
Read More

In the clinic for Feb. 24, 2026

Feb. 24, 2026
Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Eccogene, Hengrui, Kailera, Lumosa, Merrylife, Mesoblast, Takeda, Yoltech.
Read More

Financings for Feb. 24, 2026

Feb. 24, 2026
Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: Ascletis.
Read More

Appointments and advancements for Feb. 24, 2026

Feb. 24, 2026
New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Daiichi Sankyo, Nxera.
Read More

Regulatory actions for Feb. 23, 2026

Feb. 23, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Puretech, Roche.
Read More

Other news to note for Feb. 23, 2026

Feb. 23, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Beyond Air, Biocomposites, Biopharma-Middle East and Africa, Cigalah, Corcept, Fennec, Immunitybio, Seaport, Teva.
Read More

In the clinic for Feb. 23, 2026

Feb. 23, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: AC Immune, Agenus, Eli Lilly, Janssen, Johnson & Johnson, Novartis, Partner, PDS, Scandinavian, Takeda.
Read More

Financings for Feb. 23, 2026

Feb. 23, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Brainstorm Cell, Candel, Trisalus, Pharaoh.
Read More

Appointments and advancements for Feb. 23, 2026

Feb. 23, 2026
New hires and promotions in the biopharma and med-tech industries, including: Daiichi, Dymicron, Galapagos, Oculis, Pharaoh.
Read More

Biggest gainers and losers for Feb. 16-20, 2026

Feb. 23, 2026
The top 10 biopharma stock gainers and losers for the week.
Read More
Previous 1 2 … 49 50 51 52 53 54 55 56 57 … 1809 1810 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 16, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Genome sequence map

    EHA 2026: With new lenses, a changing view on pediatric cancers

    BioWorld
    In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
  • Medical illustration showing layers of a blood vessel

    Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis

    BioWorld Science
    More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
  • Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs

    BioWorld Science
    Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing